Author

Michael J. Young

  • Bioethics

    Direct-to-Patient Laboratory Test Reporting

    Petrie-Flom Student Fellow Michael Young has coauthored a new piece with Ethan Scheinberg (Harvard Law School) and Harold Bursztajn (Harvard Medical School) now available through JAMA, “Direct-to-Patient Laboratory Test Reporting: Balancing Access With Effective Clinical Communication” The article discusses…

    Direct-to-Patient Laboratory Test Reporting

  • Bioethics

    Preventing Post-hospital Syndrome

    By Michael Young Recent Center for Medicare & Medicaid regulations incentivizing reductions in 30-day hospital readmission rates have prompted a flurry of research into how clinicians and administrators can optimize patient health following hospital discharge.  Preventable hospital readmissions in the…

    Preventing Post-hospital Syndrome

  • Bioethics

    On Patents, Patients and the Public Interest

    By Michael Young Earlier this month, a U.S. District Court in Delaware issued an injunction to bar sales of a minimally invasive Medtronic replacement heart valve that putatively infringed on competitor’s Edwards Lifesciences valve system patent.…

    On Patents, Patients and the Public Interest

  • Biotechnology

    Expedited FDA Approval for Breakthrough Therapies: Promises and Pitfalls

    By Michael Young In 2012, the FDA introduced a novel pathway for expedited review of breakthrough therapies. The ‘breakthrough-drug’ designation was carved out by the Food and Drug Administration Safety and Innovation Act (FDASIA), which…

    Expedited FDA Approval for Breakthrough Therapies: Promises and Pitfalls

  • End-of-Life

    Quantifying Causes of Mortality and the Relative Burden of Disease

    By Michael J. Young “Mortis effare ordinem et serva vivos” (State the facts of the death and serve the living) It was with this incisive charge that Dr. Mark Flomenbaum concluded his lecture on forensic pathology…

    Quantifying Causes of Mortality and the Relative Burden of Disease

  • Bioethics

    Disclosing Genetic Risks: Lessons from the Philosophy of Language

    By Michael J. Young Earlier this month, landmark findings were published in the American Journal of Psychiatry illuminating the effect of disclosing genetic risk for Alzheimer’s disease on older adults’ cognition and memory.  In a…

    Disclosing Genetic Risks: Lessons from the Philosophy of Language

  • Bioethics

    Ethics and Ontology in Deep Brain Stimulation

    Petrie-Flom Center Student Fellow Michael J. Young has published a new piece in AJOB Neuroscience on “Ethics and Ontology in Deep Brain Stimulation.” From the article: Rapid advancements in the fields of neurology and neuroscience over…

    Ethics and Ontology in Deep Brain Stimulation

  • Health Care Finance

    Encouraging Innovation in Chronic Care Management

    By Michael Young The growing burden of managing chronic illness has long been a critical issue for policy makers and clinicians seeking to improve the quality, cost and efficiency of healthcare systems in the United…

    Encouraging Innovation in Chronic Care Management

  • Biotechnology

    Capturing Value in Advanced Medical Imaging

    By Michael S. Young On December 12, a bipartisan bill entitled the Excellence in Diagnostic Imaging Utilization Act of 2013 (HR 3705) was introduced in the House of Representatives which would require clinicians to use electronic…

    Capturing Value in Advanced Medical Imaging

  • Biotechnology

    Ethics and Oversight in Recombinant Genetic Research

    By Michael Young In 1972, biochemist Paul Berg and his student Janet Mertz published groundbreaking details of their first successful attempt at devising a procedure to cleave separate pieces of DNA and recombine them into…

    Ethics and Oversight in Recombinant Genetic Research